China Medical System Holdings Limited (HKG:0867)
Hong Kong
· Delayed Price · Currency is HKD 7.45
-0.46 (-5.82%)
Mar 31, 2025, 4:08 PM HKT
HKG:0867 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 7,469 | 8,013 | 9,150 | 8,337 | 6,946 | Upgrade
|
| Revenue Growth (YoY) | -6.79% | -12.43% | 9.75% | 20.03% | 14.36% | Upgrade
|
| Cost of Revenue | 2,047 | 1,937 | 2,115 | 2,090 | 1,812 | Upgrade
|
| Gross Profit | 5,422 | 6,076 | 7,036 | 6,247 | 5,134 | Upgrade
|
| Selling, General & Admin | 3,442 | 3,168 | 3,358 | 2,981 | 2,304 | Upgrade
|
| Research & Development | 329.98 | 195.13 | 125.43 | 114.76 | 66.52 | Upgrade
|
| Operating Expenses | 3,772 | 3,363 | 3,483 | 3,096 | 2,371 | Upgrade
|
| Operating Income | 1,650 | 2,713 | 3,552 | 3,151 | 2,763 | Upgrade
|
| Interest Expense | -38.61 | -46.25 | -49.09 | -28.27 | -27.52 | Upgrade
|
| Interest & Investment Income | 128.06 | 177.1 | 105.52 | 81.85 | 61.03 | Upgrade
|
| Earnings From Equity Investments | 341.3 | 277.87 | 65.06 | 75.35 | 153.8 | Upgrade
|
| Currency Exchange Gain (Loss) | -53.15 | 31.54 | -126.21 | 22.62 | 60.56 | Upgrade
|
| Other Non Operating Income (Expenses) | 90.76 | -46.82 | 127.48 | 58.57 | 33.24 | Upgrade
|
| EBT Excluding Unusual Items | 2,119 | 3,106 | 3,675 | 3,361 | 3,044 | Upgrade
|
| Impairment of Goodwill | - | - | -60 | -20 | -170 | Upgrade
|
| Gain (Loss) on Sale of Investments | -109.03 | -60.75 | 150.01 | 115.66 | -0.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.5 | -0.27 | -0.4 | -0.23 | -0.15 | Upgrade
|
| Asset Writedown | - | -171.49 | -2 | - | -57.6 | Upgrade
|
| Pretax Income | 2,010 | 2,874 | 3,763 | 3,457 | 2,816 | Upgrade
|
| Income Tax Expense | 397.23 | 489.34 | 486.66 | 431.33 | 260.39 | Upgrade
|
| Earnings From Continuing Operations | 1,613 | 2,384 | 3,276 | 3,025 | 2,556 | Upgrade
|
| Minority Interest in Earnings | 6.71 | 16.51 | -17.2 | -7.86 | -25.3 | Upgrade
|
| Net Income | 1,620 | 2,401 | 3,259 | 3,017 | 2,530 | Upgrade
|
| Net Income to Common | 1,620 | 2,401 | 3,259 | 3,017 | 2,530 | Upgrade
|
| Net Income Growth | -32.53% | -26.33% | 8.01% | 19.25% | 29.05% | Upgrade
|
| Shares Outstanding (Basic) | 2,427 | 2,452 | 2,454 | 2,468 | 2,472 | Upgrade
|
| Shares Outstanding (Diluted) | 2,427 | 2,452 | 2,454 | 2,468 | 2,472 | Upgrade
|
| Shares Change (YoY) | -1.00% | -0.08% | -0.56% | -0.17% | -0.34% | Upgrade
|
| EPS (Basic) | 0.67 | 0.98 | 1.33 | 1.22 | 1.02 | Upgrade
|
| EPS (Diluted) | 0.67 | 0.98 | 1.33 | 1.22 | 1.02 | Upgrade
|
| EPS Growth | -31.85% | -26.27% | 8.61% | 19.45% | 29.50% | Upgrade
|
| Free Cash Flow | 1,236 | 2,475 | 3,535 | 2,471 | 2,654 | Upgrade
|
| Free Cash Flow Per Share | 0.51 | 1.01 | 1.44 | 1.00 | 1.07 | Upgrade
|
| Dividend Per Share | 0.268 | 0.392 | 0.534 | 0.491 | 0.414 | Upgrade
|
| Dividend Growth | -31.55% | -26.70% | 8.84% | 18.66% | 31.20% | Upgrade
|
| Gross Margin | 72.60% | 75.82% | 76.89% | 74.93% | 73.92% | Upgrade
|
| Operating Margin | 22.10% | 33.85% | 38.82% | 37.80% | 39.78% | Upgrade
|
| Profit Margin | 21.69% | 29.96% | 35.62% | 36.19% | 36.43% | Upgrade
|
| Free Cash Flow Margin | 16.55% | 30.89% | 38.63% | 29.63% | 38.22% | Upgrade
|
| EBITDA | 1,886 | 2,922 | 3,762 | 3,357 | 2,960 | Upgrade
|
| EBITDA Margin | 25.25% | 36.47% | 41.11% | 40.27% | 42.62% | Upgrade
|
| D&A For EBITDA | 235.74 | 209.3 | 209.08 | 206.05 | 197.06 | Upgrade
|
| EBIT | 1,650 | 2,713 | 3,552 | 3,151 | 2,763 | Upgrade
|
| EBIT Margin | 22.10% | 33.85% | 38.82% | 37.80% | 39.78% | Upgrade
|
| Effective Tax Rate | 19.76% | 17.03% | 12.93% | 12.48% | 9.25% | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.